The role of glutamate in behavioral and neurotoxic effects of methamphetamine

Neurochemistry International

Volumn 29, Issue 3, 1996, Pages 301-307

  Ohmori, T ^a   Abekawa, T ^a   Koyama, T ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; METHAMPHETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; MICRODIALYSIS; NEUROCHEMISTRY; NEUROTOXICITY; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION;

ANIMALIA;

EID: 0030247335     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/0197-0186(95)00152-2     Document Type: Article

References (41)

1. Abekawa T., Ohmori T., Koyama T. Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens. Brain Res. 643:1994;276-281.
2. Abekawa T., Ohmori T., Koyama T. Effects of NO synthase inhibition on behavioral changes induced by a single administration of methamphetamine. Brain Res. 666:1994;147-150.
3. Abekawa T., Ohmori T., Koyama T. Effects of nitric oxide (NO) synthesis inhibition on the development of supersensitivity to stereotypy and locomotion stimulating effects of methamphetamine. Brain Res. 679:1995;200-204.
4. Ali S.F., Newport G.D., Holson R.R., Slikker W. Jr., Bowyer J.F. Low environmental temperatures or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice. Brain Res. 658:1994;33-38.
5. Bakhit C., Morgan M.E., Peat M.A., Gibb J.W. Long-term effects of methamphetamine on the synthesis and metabolism of 5-hydroxytryptamine in various regions of the rat brain. Neuropharmacology. 20:1981;1135-1140.
6. Barondes S.H. Cerebral protein synthesis inhibitors block long-term memory. Int. Rev. Neurobiol. 12:1970;177-205.
7. Bowyer J.F., Davis D.L., Schmued L., Broening H.W., Newport G.D., Slikker W. Jr., Holson R.R. Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J. Pharmac. Exp. Ther. 268:1994;1571-1580.
8. Collingridge G.C., Singer W. Excitatory amino acid receptors and synaptic plasticity. Trends Pharmac. Sci. 11:1990;290-296.
9. Dingledine R., McBain C.J., McNamara J.O. Excitatory amino acid receptors in epilepsy. Trends. Pharmac. Sci. 11:1990;334-338.
10. Elrod K., Buccafusco J.J. An evaluation of the mechanism of scopolamine-induced impairment in two passive avoidance protocols. Pharmac. Biochem. Behav. 29:1988;15-21.
11. Fagg G.E., Foster A.C. Amino acid neurotransmitters and their pathways in the mammalian central nervous system. Neuroscience. 9:1983;701-719.
12. Green A.R., De Souza R.J., Williams J.L., Murray T.K., Cross A.J. The neurotoxic effects of methamphetamine on 5-hydroxytryptamine and dopamine in brain: evidence for the protective effect of chlormethiazole. Neuropharmacology. 31:1992;315-321.
13. Hirotsu I., Hori N., Katsuda N., Ishihara T. Effect of anticholinergic drug on long-term potentiation in rat hippocampal slices. Brain Res. 482:1989;194-197.
14. Hotchkiss A.J., Gibb J.W. Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. J. Pharmac. Exp. Ther. 214:1980;257-262.
15. Johnson M., Hanson G.R., Gibb J.W. Effect of MK-801 on the decrease in tryptophan hydroxylase induced by methamphetamine and its methylenedioxy analog. Eur. J. Pharmac. 165:1989;315-318.
16. Kalivas P.W., Stewart J. Dopamine transmission in the initiation and expression of drug-and stress-induced sensitization of motor activity. Brain Res. Rev. 16:1991;223-244.
17. Karler R., Calder L.D., Chaudhry I.A., Turkanis S.A. Blockade of reverse tolerance to cocaine and amphetamine by MK-801. Life Sci. 45:1989;599-606.
18. Karler R., Finnegan K.T., Calder L.D. Blockade of behavioral sensitization to cocaine and amphetamine by inhibitors of protein synthesis. Brain Res. 603:1993;19-24.
19. Krebs M.O., Desce J., Kemel M.L., Gauchy C., Godeheu G., Cheramy A., Globinski J. Glutamatergic control of dopamine release in the rat striatum: evidence for presynaptic N-methyl- D-aspartate receptors on dopaminergic nerve terminals. J. Neurochem. 56:1991;81-85.
20. McEnte W.J., Crook T.H. Glutamate: its role in learning, memory and the aging brain. Psychopharmacology. 111:1993;391-401.
21. Malenka R.C., Nicoll R.A. NMDA-receptor-dependent synaptic plasticity: multiple forms and mechanisms. Trends Neurosci. 16:1993;521-527.
22. Meldrum B., Garthwaite J. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmac. Sci. 11:1990;379-387.
23. Muraki A., Koyama T., Nakayama M., Ohmori T., Yamashita I. MK-801, a non-competitive antagonist of NMDA receptor, prevents methamphetamine-induced decrease of striatal dopamine uptake sites in the rat striatum. Neurosci. Lett. 136:1992;39-42.
24. Nakayama M., Koyama T., Yamashita I. Long-lasting decrease in dopamine uptake sites following repeated administration of methamphetamine in the rat striatum. Brain Res. 601:1993;209-212.
25. Nash J.F., Yamamoto B.K. Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine. Brain Res. 581:1992;237-243.
26. Ohmori T., Abekawa T., Koyama T. Competitive and noncompetitive NMDA antagonists sensitization of methamphetamine. Pharmac. Biochem. Behav. 48:1994;587-591.
27. Ohmori T., Abekawa T., Koyama T. Scopolamine prevents the development of behavioral sensitization. Life Sci. 56:1995;1223-1229.
28. Ohmori T., Koyama T., Muraki A., Yamashita I. Competitive and noncompetitive N-methyl- D-aspartate antagonists protect dopaminergic and serotonergic neurotoxicity produced by methamphetamine in various brain regions. J. Neural. Transm. 92:1993;97-106.
29. Ohmori T., Koyama T. and Yamashita I. (1991) Effects of N-methyl- D-aspartate and related agents on dopamine release from superfused slices of rat striatum. In NMDA Receptor Related Agents: Biochemistry, Pharmacology and Behavior(Kameyama T., Nabeshima T. and Domino E. F., Eds), pp. 129-139. NPP Books, Ann Arbor.
30. Otani S., Roisin-Lallemand M.P., Ben-Ari Y. Enhancement of extracellular protein concentrations during long-term potentiation in the rat hippocampal slice. Neuroscience. 47:1992;265-272.
31. Quinton E.E., Kramarcy N.R. Memory impairment correlates closely with cycloheximide dose and degree of inhibition of protein synthesis. Brain Res. 131:1977;184.
32. Ricaurte G.A., Schuster C.R., Seiden L.S. Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study. Brain Res. 193:1980;153-163.
33. Robinson T. E. (1991) The neurobiology of amphetamine psychosis: evidence from studies with an animal model. In Biological Basis of Schizophrenic Disorders (Nakazawa T., Ed.) pp. 185-201. Japan Scientific Society Press and Karger, Tokyo.
34. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev. 11:1986;157-198.
35. Seiden L.S., Commins D.L., Vosmer G., Axt K., Marek G. Neurotoxicity in dopamine and 5-hydroxytryptamine terminal field: a regional analysis in nigrostriatal and mesolimbic projections. Ann. NY Acad. Sci. 539:1988;161-172.
36. Seiden L. S., Fischman M. W. and Schuster C. R. (1975/76) Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys. Drug Alc. Depend. 1, 215-219.
37. Sonsalla P.K., Nicklas W.J., Heikkila R.E. Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science. 243:1989;398-400.
38. Sonsalla P.K., Riordan D.E., Heikkila R.E. Competitive and noncompetitive antagonists at N-methyl- D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice. J. Pharmac. Exp. Ther. 256:1991;506-512.
39. Stewart J., Druhan J. Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist, MK-801. Psychopharmacology. 110:1993;125-132.
40. Westerberg V., Corcoran M.E. Antagonism of central but not peripheral cholinergic receptor retards amygdala kindling in rats. Exp. Neurol. 95:1987;194-206.
41. Wolf M.E., Khasa M.R. Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine. Brain Res. 562:1991;164-168.